Multi-centric clinical trial of a vasoconstrictor-ornithine vasopressin (POR 8 Sandoz).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000768:Anesthesia, General; D000772:Anesthesia, Local; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006221:Halothane; D006801:Humans; D007223:Infant; D007267:Injections; D008297:Male; D008733:Methoxyflurane; D008875:Middle Aged; D009883:Ophthalmic Solutions; D009952:Ornithine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D014662:Vasoconstrictor Agents; D014667:Vasopressins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D009883:Ophthalmic Solutions; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D008733:Methoxyflurane; D009952:Ornithine; D006221:Halothane